Login / Signup

Using crowdsourcing to understand patients attitudes toward a clinical trial for retinitis pigmentosa requiring 4 years of participation.

Xiangrong KongCory DorfmanSusie TrotochaudFahd NaufalCarl A LatkinPeter A Campochiaro
Published in: Ophthalmic genetics (2021)
A trial requiring 4-years of commitment is feasible although retention can be challenging. Strategies including supplementing in-clinic visits with tele-visits and frequent communications may facilitate retention. This study also demonstrates a methodology useful for planning clinical trials for chronic diseases.
Keyphrases
  • clinical trial
  • phase ii
  • phase iii
  • study protocol
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • open label
  • randomized controlled trial
  • primary care
  • prognostic factors
  • double blind